Quantitative evaluation of DNA-binding data in vivo for low-dose extrapolations by Lutz, Werner K.
Mechanisms and Models in Toxicology 
Arch. Toxicol., Suppl. 11, 66-74 (1987) 
© by Springer-Verlag 1987 
Quantitative Evaluation of DNA-Binding Data In Vivo 
for Low-Dose Extrapolarions 
W.K.Lutz 
Institute of Toxicology, ETH and University of Zurich, CH-8603 Schwerzenbach, Switzerland 
Introdu.ction 
The risk oftumor formation from exposure to a chemical carcinogen is dependent 
on the exposure, the potency of the carcinogen, and the imiividual host reaction. 
Rumans are exposed to chemical carcinogens at dose levels which are orders of 
magnitude below the levels used in"animal studies on carcinogenicity. The latter 
experiments provide significant data only at high-dose levels which lead to tumor 
incidences on the order ofpercent (Fig.1). For humans, tolerable exposures pro-
ducing not more than one additional tumor in one million lives should be defined. 
The extrapolation range therefore covers four to five orders of magnitude. In-
stead of using purely mathematical models for the extrapolation, it woulä. be de-
sirable to have a biologically relevant indicator which could be investigated in the 
dose range to be bridged. 
A large group of chemical carcinogens is known to bind covalently to DNA 
in the target cell. Under appropriate conditions, this primary DNA lesion can be 
expressed as a mutation finally leading to cancer. The primary interaction of the 
· carcinogen with DNA can be investigated with appropriate techniques (radiola-
beled test compound, phosphorylation with 32P, or immunological methods) at 
low dose levels which would not give rise to a detectable increase in tumor yield 
with a limited number of animals treated. It is therefore possible to investigate 
the shape of the dose-response curve in the region of interest. 
Methods 
With radiolabeled test compound,. the limit of detection is dependent on the spe-
cific activity, on the binding potency ( covalent binding index, CBI; Lutz 1979), 
on the amount of DNA analyzed, and on the radioactivity in a vial considered 
significant. U nder optimal conditions met, for instance, with tritiated aflatoxin 
B 1 of 8 Ci/mmol and a CBI of 10 000, a single dose of 1 ng/kg rat was the o bserved 
limit of detection for liver DNA binding (1 0 dpm net radioactivity in 6 mg DNA). 
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Fig.l. Cumulative tumor incidence in rats as a function of the level of exposure. For aflatoxin B1 
(AFB1) and saccharin (Sacch) the compound was admixed to the diet; the bottom dose scale applies. 
For formaldehyde (FA) and vinyl chloride (VC) exposure was by inhalation, 6 h/day, 5 daysjweek, for 
2 years; the top dose scale applies. The two scales were combined on the assumption of a respiratory 
minute volume of750 ml air/kg and an absorption of20% 
This corresponded to 3 adducts per 1011 nucleotides, i.e., less than 1 adduct per 
liver cell genome. With 14C-labeled compounds of 10 mCi/mmol, the limit of de- · 
tection would have been about 500 times higher, i.e., 1 adduct in 108 nucleo-
tides. 
A model calculation for the postlabeling technique using HPLC methods gives 
the following results: With [y-32P]ATP of a specific activity of 1000 Ci/mmol, an 
assumed limit of detection of 20 dpm would correspond to 0.01 fmol adduct, i.e., 
a level of 3 in 109 nucleotides in a 1-llg DNA sample. 
With antibodies and the slot-blot technique (Rajewsky, personal communica-
tion), 0.1 fmol adduct can be detected in 3 [lg DNA. This corresponds to an ad-
duct level of 1 in 108 nucleotides. 
A comparison of the three methods therefore shows that for the testing of new 
compounds, and where only small amounts ofDNA are available from a specific 
tissue, the postlabeling technique seems most versatile. 
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Theoretical Considerations of the Shape of the Dose-Response Curve 
~or DNA Binding 
Many ofthe DNA-binding carcinogens require metabolic activation to form elec-
trophilic, reactive, so-called ultimate carcinogens. DNA binding therefore in-
volves enzymatic processes, diffusion processes, and electrophilic substitution 
reactions. In principle, the rate of all these steps is proportional to the concentra-
tion in the low range, so that a linear dose-DNA binding relationship would be 
postulated. The rate ofDNA repair has been found tobe proportional to the level 
of the DNA adducts in the case of 0 6-methylguanine (Lutz 1982). If this first 
order kinetics for DNA repair holds also for other adducts, a linear dose-DNA 
binding relationship would hold not only for the time of maximum binding, but 
also at later times of DNA analysis. 
Experimental Findings on the Dose-DNA Binding Relationship 
A number of compounds have been studied in this respect. The dose range inves-
tigated is shown in Fig. 2. A small arrow indicates for each compound the TD 50 
2-AAF Diet, M. divl 1 ONA, r, Jackson I 
jEMS i.p., M, liv&Kid, DNA, Murthvl 
jDMNA i.p.,f H, Uv, DNA. Stumpd 
p. o., R & M, Hb, Pereira 1 I 
lt-DMAS p. o., R, Liv, DNA, Gauoler I 
IDMNA p.o. &i.v., R, Livv &Kid, ONA, Peggl. 
BP p. o., M, Liv&Stom, DNA, V Dunnl 
BP B'paint, M, Epid, DNA, PereirJ 1 
jt-DMAS p.o., R,Liv&Kid,DNA, Neuman:l 
!AFB 1 . i.p., R, Li~~ DNA, Appleton y r To 50 jAFB 1 p.o., R, Liv,! DNA, s&r, Caviezell 
! I I T I I 
-8 
-7 -6 -5 -4 -3 '-2 -1 
Dose range log (mmo!/kg) 
Fig.2. Range of doses investigated with various carcinogens for macromolecular binding in vivo. The 
small arrows indicate the TD50 value (Gold et al. 1984), i.e., a measure for carcinogenic potency. Ab-
breviations of substances from left to right: AFB1 , aflatoxin B1 ; t-DMAS, trans-4-dimethylaminostil-
bene; BP, benzo[a]pyrene; DMNA, dimethylnitrosamine; EMS, ethylmethanesulfonate; 2-AAF, 2-ace-
tylaminofluorene. Other abbreviations indicate the route of exposure, the animal species, the organ of 
interest, the type of macromolecule, and a specification of single (s) or repeated (r) administration: R, 
rat; M, mouse; H, hamster; Liv, liver; kid, kidney; Epid, epidermis; Stom, stomach; Lun, Jung; F'sto, 
forestomach; div, diverse organs; Hb, hemoglobin. The respective reference is listed under the first 
author's name. (From P. Buss, Ph.D. thesis, ETH Zurich, in preparation) 
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Fig.3. Dose-response curve for the determination of 7-methylguanine (7-mG) and 0 6-methylguanine 
( 0 6-mG) in liver DNA isolated from male ~yrian golden hamsters, 5 h after i.p. injection of radiola-
beled dimethylnitrosamine (DMNA). (Original data from Stumpf et al. 1979) 
value (Gold et al. 1984), i.e., the approxirnate daily dose required to induce a tu-
mor in 50% ofthe anirnals treated. With respect to the problern of extrapolation 
of turnor-inducing doses to lower exposures, those studies are the rnost relevant 
which cover three Oi' rnore orders of rnagnitude below the TD50 . Studies which 
did not extend beyond one order of rnagnitude below the TD 50 were not included 
in the list. All studies except those investigating specific rnethylated DNA bases 
showed a linear dose-response curve. The lowest dose used was 1 ngjkg with af-
latoxin B1 (Caviezel 1984). The theoretical prediction of proportionality could 
therefore be verified experirnentally. 
The only situation showing a nonlinearity is exernplified in Fig. 3. The forrna-
tion of 7-rnethylguanine increased linearly with the DMNA dose, whereas the 
level of 0 6-rnethylguanine was proportional to the dose only above 0.5 rngjkg. 
Below that dose, the level of 0 6-rnethylguanine was lower than extrapolated frorn 
the high dose levels. This phenornenon was indicative of a fast-acting repair 
process which was exhausted at higher levels of 0 6-rnethylguanine (Lutz 1982). 
F or this adduct it could also rnean that a linear extrapolation of the turnor 
incidence data to lower doses might be too conservative because a srnall DNA 
darnage rnight be rnore quickly repaired than a large one. A nonlinear dose-
response relationship results. Since DNA rnethylation so far is the only DNA 
darnage leading to this type of dose response it is possible that this constitutive, 
fast repair of erroneous DNA rnethylations has evolved in nature in order to 
control errors in the forrnation of 5-rnethylcytidine by the endogenous rnethyl 
donor S-adenosylrnethionine. 
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It is becoming evident that DNA binding is nonrandom with respect both to 
sequence and arrangement of the DNA. This does interfere with the quantitative 
relationship of total DNA binding to the number of critical mutations, but it 
should not affect the analysis of the dose-response relationship because it can be 
assumed that the fraction of critical adducts will be proportional to the total 
number of adducts. 
Single V s Repetitive Exposure 
In a standard carcinogenicity bioassay, the test compound is given continuously. 
The level of DNA adducts therefore is a result of a constant daily increase from 
new exposure and the removal by repair, cell death, or cell division. What is de-
cisive for the tumorigenicity of DNA adducts in the steady-state level. Only two 
studies have been dealing with the low dose-response relationship for DNA bind-
ing afterrepetitive exposure. 
1. Various conce11trations of 2-acetylaminofluorene (2-AAF) were admixed to 
the diet fed for 2 weeks to mice of different strains. DNA was isolated from 
different organs. The level of DNA adducts was strictly proportional to the 
concentration of 2-AAF in the diet (Jackson et al. 1980). 
? In this laboratory, tritiated aflatoxin B1 was administered p.o. to F344 rats on 
. 10 consecutive days (Cavieze11984). Liver DNA was isolated 24 h after the last 
dose and the level of DNA tlamage was determined. Again, a linear dose-re-
sponse relationship was found over 4 orders of magnitude (Fig. 4). The darn-
age set by the highest dosewas no Ionger proportional to the dose, probably 
because of a saturation of the activating enzyme systems. This phenomenon 
was also observed with DNA adducts induced by trans-4-dimethylaminostil-
bene (t-DMAS; Neumann 1980) and vinyl chloride (Watanabe et al. 1978) and 
is reflected in earcinogenicity studies by a flattening out of the dose-response 
curve at the highest exposure levels (see Fig.1 vinyl chloride, VC). 
Conclusions on DNA-Binding in Exposed Individuals 
The data summarized above indicate that the level of genotoxicity is proportional 
to the dose in the low dose range after both single and repetitive administration 
of a DNA-binding compound. In the high dose range, a flattening out ofthe curve 
can be seen if the metabolic activation is becoming saturated. 
The lowest dose used so Jar for a DNA-binding study was 1 ng aflatoxin B1 
administered per kg rat. This corresponds to about 60 ng per man, i.e., a dose 
which is taken up daily in certain areas of tropical Africa and Asia. The lowest 
point shown in Fig. 4 therefore represents a dose to which humans can be ex-
posed. 
For risk extrapolation of DNA-binding carcinogens it therefore seems most 
appropriate to underline the idea that the primary lesion is strictly proportional 
to the dose. The nonlinearity seen with 0 6 -methylguanine is one exception to the 
rule and probably cannot be used for other types of adducts. 
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Fig. 4. Binding of tritiated aflat?xin B1 (AFB1 ) to liver DNA of male F344 rats, 24 h after one single 
(lx) or the last often daily oral doses (lOx), as a function ofthe dose 
Low-Dose Extrapolations in Populations 
Both theoretical analysis and experiD:J-ental data indicate that, for the primary le-
sion in chemical carcinogenesis by DNA-binding compounds, a linear extrapola-
tion is appropriate. This proportionality cannot, however, be extended to the 
question ofthe dose-response relationship for the appearance oftumors in a pop-
ulation without additional considerations. In general toxicology it is very often 
seen that the distribution of individuals giving a predetermined response (yes or 
no criterion) to an agey.t is gaussian (normal) if the doses are scaled logarithmi-
cally. This log-normal distribution can be derived exactly from the reasonable 
pharmacological assumption that the effect will become observable ifthe concen-
tration of the toxic principle is above a certain limit during a critical period of time·. 
If it is further accepted that the individuals in the population differ according to 
anormal distribution with respect to either the critical time period necessary or 
the rate of detoxication, the values of a minimal effective concentration will be 
log-normally distributed (Koch 1966). 
An element of time is therefore required for the logarithm to enter into the 
dose-response relationship. Timeis also of predominant importance in the pro-
cess of chemical carcinogenesis, but here it is not a matter of an all or none re-
sponse, but rather of a stochastic succession of stages where the probability is de-
pendent on the period of time available. For instance, a heritable mutation can 
only be derived from a DNA adduct if the DNA is replicating to produce a genetic 
alteration in a daughter cell. The fixation ofthe primary lesion is therefore depen-
dent on the relative rates of DNA repair and DNA replication. A reduction of 
the time available for the mutational expression ofthe DNA adduct will therefore 
reduce the probability of a mutation. 
Many mathematical risk models take into account that carcinogenesis is a mul-
tistage process with several hits being required with or without specific sequence 
W.K.Lutz 
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tions The observed tumor incidences are used to determine best-fit values 
assump · - 1 · f · If h f · ' " ' 
,.. the parameters of the under ymg unctwn. _ suc unctwns are usea ror lOW-~~se extrapolations, an unresolvable problern arises from the assumption that the 
host reaction to the high dose levels also determines the shape of the dose-re-
sponse curve at lower dose levels (FDA 1971). 
Dose-Response Relationship for Combination Mechanisms 
of Carcinogenic Action 
DNA binding is on1y one out of a number of activities resulting in increased tu-
mor formation (Lutz 1986). Cell division seems to be an absolute requirement in 
carcinogenesis, and agents or processes which stimulate the rate ofDNA synthe-
sis are often found to increase the tumor incidence. Some compounds most prob-
ab1y produce DNA adducts and stimulate cell division: hexach1orocyclohexane 
isomers could be named (Sagelsdorff et al. 1983) and formaldehyde might also be 
an examp1e (Swenberg et al. 1983). In both cases it is considered that the DNA-
binding activity is low so that it would not a1one be sufficient to lead to a 
significant increase in tumor formation in a standard bioassay (Fig. 5, dashed 
line). Only together with sufficient promotion would an effect become observable. 
With formaldehyde, this promoting activity- in a mechanistic sense- could be 
due to cytotoxicity and tissue regeneration. Since cell death is an "all or nothing" 
phenomenon, discussed above," as the basis of a log-normal dose-response 
relationship, a nonlinear curve could result. A combination ofDNA binding with 
stimulation of cell division would still be nonlinear (Fig. 5). The steep slope 
observed for the tumor incidence from formaldehyde inhalation exposure to 5.6 
and 14.3 ppm (Fig.1) could therefore be explained by a combination of direct 
genotoxicity and tissue irritation. 
The slope shown for aflatoxin B1 and vinyl chloride (low dose part only) is ap-
proximately one in the double-log plot. The proportionality of dose and I)NA 
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Fig. 5. Potentialdose-response relationship for a chemical carcinogen exhibiting more than one biolog-
ical activity related to tumor induction. Cytotoxicity with regenerative cell division is given as one pos-
sib1e example for a promoting type activity 
DNA-Binding at Low Doses 73 
binding as discussed above therefore seems to determine the dose-response rela-
tionship for the tumor incidence. This could mean that DNA binding is the pre-
dominant factor in chemical carcinogenesis by AFB 1 and VC. DNA binding is 
only one mechanism of genotoxicity. Stimulation of cell division is only one 
aspect in tumor promotion. The present analysis of the available data shows that 
these two aspects might explain tumor formation by a large nurober of chemicals. 
Nevertheless, other types of activities might be involved in the process of carcino-
genesis. Such critical biochemical processes should be searched for. 
The present discussion has shown that the assessment of the risk of exposure 
to a tumor-inducing agent at low dose levels could be improved if mechanisms 
of action were taken into account. Low-dose extrapolations should therefore be 
based more often on biological models. Neither standard carcinogenicity bioas-
says nor mathematical models provide such information. 
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